These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 11366070)

  • 1. Time for a change?
    Little S; del Rio C
    AIDS Clin Care; 1998 Dec; 10(12):92, 98. PubMed ID: 11366070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV neuropathy risk factors and symptom characterization in stavudine-exposed South Africans.
    Wadley AL; Cherry CL; Price P; Kamerman PR
    J Pain Symptom Manage; 2011 Apr; 41(4):700-6. PubMed ID: 21145196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased incidence of peripheral neuropathy with co-administration of stavudine and isoniazid in HIV-infected individuals.
    Breen RA; Lipman MC; Johnson MA
    AIDS; 2000 Mar; 14(5):615. PubMed ID: 10780724
    [No Abstract]   [Full Text] [Related]  

  • 4. Too little of a good thing.
    Friedland GH; Gulick RM
    AIDS Clin Care; 1998 Oct; 10(10):76-7. PubMed ID: 11365860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon.
    Laurent C; Bourgeois A; Mpoudi-Ngolé E; Ciaffi L; Kouanfack C; Mougnutou R; Nkoué N; Calmy A; Koulla-Shiro S; Delaporte E
    AIDS Res Hum Retroviruses; 2008 Mar; 24(3):393-9. PubMed ID: 18327976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age and height predict neuropathy risk in patients with HIV prescribed stavudine.
    Cherry CL; Affandi JS; Imran D; Yunihastuti E; Smyth K; Vanar S; Kamarulzaman A; Price P
    Neurology; 2009 Jul; 73(4):315-20. PubMed ID: 19636052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stavudine-associated peripheral neuropathy in zidovudine-naïve patients: effect of stavudine exposure and antiretroviral experience.
    Scarsella A; Coodley G; Shalit P; Anderson R; Fisher RL; Liao Q; Ross LL; Hernandez JE
    Adv Ther; 2002; 19(1):1-8. PubMed ID: 12008857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactate concentrations distinguish between nucleoside neuropathy and HIV neuropathy.
    Brew BJ; Tisch S; Law M
    AIDS; 2003 May; 17(7):1094-6. PubMed ID: 12700465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stavudine- and nevirapine-related drug toxicity while on generic fixed-dose antiretroviral treatment: incidence, timing and risk factors in a three-year cohort in Kigali, Rwanda.
    van Griensven J; Zachariah R; Rasschaert F; Mugabo J; Atté EF; Reid T
    Trans R Soc Trop Med Hyg; 2010 Feb; 104(2):148-53. PubMed ID: 19732926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case for proactive switching?
    Craven D; Vella S
    AIDS Clin Care; 1999 Aug; 11(8):66-7. PubMed ID: 11366438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double "d" drug danger.
    Moyle G
    AIDS Read; 2003 Jan; 13(1):15-6, 23-4. PubMed ID: 12569891
    [No Abstract]   [Full Text] [Related]  

  • 12. Brief Report: Demographic and Genetic Associations With Markers of Small and Large Fiber Sensory Neuropathy in HIV Patients Treated Without Stavudine.
    Safri AY; Gaff J; Octaviana F; Setiawan DD; Imran D; Cherry CL; Laws SM; Price P
    J Acquir Immune Defic Syndr; 2020 Dec; 85(5):612-616. PubMed ID: 32925363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usage of stavudine (D4T) - a retrospective analysis in a South London hospital.
    Lechelt M; McCormick S; de Ruiter A
    Int J STD AIDS; 2007 Mar; 18(3):215-7. PubMed ID: 17362559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients.
    Idoko JA; Akinsete L; Abalaka AD; Keshinro LB; Dutse L; Onyenekwe B; Lhekwaba A; Njoku OS; Kehinde MO; Wambebe CO
    West Afr J Med; 2002; 21(2):83-6. PubMed ID: 12403023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxyurea in combination with didanosine and stavudine in antiretroviral-experienced HIV-infected subjects with a review of the literature.
    Rossero R; Asmuth DM; Grady JJ; McKinsey DS; Green S; Andron L; Pollard RB
    Int J STD AIDS; 2003 May; 14(5):350-5. PubMed ID: 12803944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Focal mycobacterial lymphadenitis after starting highly active antiretroviral therapy].
    Schwietert M; Battegay M
    Dtsch Med Wochenschr; 1999 Jan; 124(3):45-8. PubMed ID: 9987485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in CAMKK2 associate with susceptibility to sensory neuropathy in HIV patients treated without stavudine.
    Gaff J; Octaviana F; Ariyanto I; Cherry C; Laws SM; Price P
    J Neurovirol; 2019 Dec; 25(6):814-824. PubMed ID: 31309408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleoside analogues and mitochondrial toxicity.
    Fleischer R; Boxwell D; Sherman KE
    Clin Infect Dis; 2004 Apr; 38(8):e79-80. PubMed ID: 15095236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral neuropathy in patients with HIV infection: consider dual pathology.
    Miller RF; Bunting S; Sadiq ST; Manji H
    Sex Transm Infect; 2002 Dec; 78(6):462-3. PubMed ID: 12473814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the change from Stavudine to tenofovir in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy: studies on mitochondrial toxicity and thymic function.
    Rosso R; Nasi M; Di Biagio A; Repetto E; Dentone C; Pinti M; Nemes E; Ferraresi R; Mussini C; Esposito R; Viscoli C; Cossarizza A
    Pediatr Infect Dis J; 2008 Jan; 27(1):17-21. PubMed ID: 18162932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.